On Thursday June 22, the Drug Enforcement Administration (DEA) published a final rule, amending the regulations regarding DEA Form 106. Learn more.
Information
Clarification of Opioid Continuing Education Requirement Under ABC-map (PDF)
Contact Lens Rule (PDF)
50 State Comparison Report: A Comparison of State Occupational Licensure Requirement and Processes
Act 6 of 2018 Notice to All Licensees, Registrants, Certificate Holders & Permit Holders (PDF)
Notice - Act 65 Of 2023 Expungement Provisions (PDF)
Act 31 of 2014 Mandated Child Abuse Recognition and Reporting
Fentanyl Safety Recommendations (PDF)
Department of Health Notice; Cetirizine ophthalmic solution (Zerviate®) 0.24% (PDF)
Pennsylvania's Prescription Drug Monitoring Program
Naloxone Frequently Asked Questions
Naloxone Prescription for Overdose Prevention (PDF)
Naloxone for Opioid Safety - A Provider's Guide to Prescribing to Patients Who Use Opioids (PDF)
Veteran's Administration Hospitals-License Verification (PDF)
American Board of Optometry (ABO) Board Certification (PDF)
DEA Rescheduling Hydrocodone Products (PDF)
Drugs Approved for PA Optometrists - December 2024 (PDF)
PA Guidelines
Pennsylvania has taken significant steps to improve prescribing practices for pain and related conditions. You can find guidelines for various medical specialties on the safe and effective use of opioids and other controlled substances from the Safe and Effective Prescribing Practices Task Force.